September 17, 2020
C-Path Launches Consortium to Accelerate Medical Product Development in Sickle Cell Disease
Related Posts
-
C-Path Appoints Health Outcomes Expert as Executive Director of the Rare Disease COA Consortium -
C-Path Launches Rare Disease Clinical Outcome Assessment Consortium
-
C-Path’s ePRO Consortium Announces Rebranding, Changes Name to eCOA Consortium -
DiMe Journal Club features Critical Path for Parkinson’s 3DT initiative -
Welcome uMotif